0.0000 (0.0000%)
  • Bid / Lots
    2.8300/ 35
  • Ask / Lots
    3.5000/ 26
  • Open / Previous Close
    0.0000 / 3.1000
  • Day Range
  • 52 Week Range
    Low 1.7801
    High 4.4300
  • Volume
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 3.05
09:32 ET5233.14
09:33 ET3003.05
09:37 ET2003.09
09:39 ET1003.12
09:44 ET1003.11
09:48 ET5573.08
09:51 ET2003.07
09:53 ET1003.0837
09:55 ET5003.083
10:00 ET21003.0999
10:04 ET48003.11
10:06 ET15003.1001
10:08 ET37003.13
10:11 ET1003.13
10:15 ET11003.13
10:18 ET1003.115
10:22 ET1003.13
10:26 ET7433.155
10:31 ET1003.18
10:36 ET1003.17
10:42 ET14003.1437
10:47 ET1003.15
10:54 ET1003.16
10:56 ET1003.15
10:58 ET1003.15
11:03 ET1003.15
11:09 ET1003.15
11:18 ET1003.15
11:20 ET2203.13
11:23 ET6003.15
11:30 ET1003.15
11:34 ET8003.14
11:36 ET1003.14
11:38 ET6003.1101
11:39 ET29273.111
11:41 ET37993.1
11:43 ET20003.0901
11:48 ET4003.14
11:50 ET25003.15
11:57 ET1003.15
12:01 ET3003.11
12:12 ET1003.15
12:28 ET23113.1125
12:33 ET17753.12
12:42 ET2003.1199
12:50 ET1003.1199
12:51 ET1173.12
12:53 ET2003.11
01:02 ET2553.14
01:13 ET15003.09
01:33 ET1003.12
01:40 ET1003.12
01:49 ET1003.12
02:25 ET1003.12
02:56 ET43683.1
02:57 ET3003.15
03:21 ET10713.1077
03:32 ET3643.11
03:37 ET5003.1
03:39 ET2003.0801
03:53 ET1003.1
03:55 ET19003.0948
03:57 ET22003.0885
04:00 ET68723.1
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOCUP
Ocuphire Pharma Inc
United StatesPMCB
PharmaCyte Biotech Inc
United StatesORTX
Orchard Therapeutics PLC
United StatesEQ
Equillium Inc
United StatesASPI
ASP Isotopes Inc
United StatesEDTXF
Spectral Medical Inc
As of 2022-12-08

Company Information

Ocuphire Pharma, Inc. is an ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its products include Nyxol Eye Drops and APX3330. The Nyxol Eye Drops is a once-daily preservative-free eye drop formulation of phentolamine mesylate designed to reduce pupil diameter and improve visual acuity. Nyxol is being developed for several indications, including night vision disturbances, reversal of pharmacologically induced mydriasis and presbyopia. The APX3330, is a twice-a-day oral tablet, designed to inhibit angiogenesis and inflammation pathways relevant to retinal and choroidal vascular diseases. Its pre-clinical products are APX2009 and APX2014. APX3330 is in Phase II trial for the treatment of patients with diabetic retinopathy (DR), including moderately severe non-proliferative DR and mild proliferative DR, as well as patients with diabetic macular edema (DME) without loss of central vision.

Contact Information

37000 Grand River Ave., Suite 120FARMINGTON HILLS, MI, United States 48335


Independent Chairman of the Board
Cam Gallagher
President, Chief Executive Officer, Vice Chairman of the Board, Treasurer
Mina Sooch
Principal Accounting Officer, Vice President - Finance
Amy Rabourn
Vice President - Corporate Development and Operations
Bernhard Hoffmann
Lead Independent Director
Sean Ainsworth

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.